Navigation Links
K-State Trauma Researcher Says Being Prepared, Taking Action Are Vital in Preventing Tragedies Like the One at NIU
Date:2/18/2008

MANHATTAN, Kan., Feb. 18 /PRNewswire-USNewswire/ -- Be aware, be prepared and take action.

That's the advice from a Kansas State University trauma expert on preventing tragedies like the one recently at Northern Illinois University.

K-State's Briana Nelson Goff, associate dean of K-State's College of Human Ecology and associate professor of family studies and human services, leads the Trauma Research, Education and Consultation at K-State, or TRECK Team.

K-State's TRECK Team focuses on conducting research and educating professionals and the public about traumatic events and how they affect individuals, families and institutions.

Although no preventive measure is foolproof, Goff said there are things individuals and institutions can do to help prevent tragedies like the one at NIU and the one at Virginia Tech in spring 2007.

The first thing is to pay attention to those around you. Research has shown that people are reluctant to get involved or do not feel equipped to help, Goff said.

"Learn to recognize cries for help -- which aren't always vocal - and take them seriously. Note changes in behavior such as withdrawing from others, becoming increasingly angry or being uncommonly absent from class or work," she said. "A counselor might recognize symptoms and know how to deal with them, but someone without training might not. We need to help faculty and staff gain skills to help students and colleagues."

Another important key is for institutions to have a plan of action that includes safety and communications. Most probably believe they are prepared until something happens, Goff said.

"Clearly, after the Virginia Tech tragedy last April, universities are working to prepare for this type of event," Goff said. "Preliminary reports after the NIU shootings indicate very swift action by campus officials, with the notification system, and by students in the classroom and outside the building." '/>"/>

SOURCE Kansas State University
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
2. K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent
3. Professionals in bioscience, food-related industries turn to K-State
4. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
5. Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury
6. Global Experts Convene to Discuss Emotional Trauma Caused by Disasters
7. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
8. Change in trauma level designation associated with improved patient survival
9. Study suggests some brain injuries reduce the likelihood of post-traumatic stress disorder
10. Predicting post-traumatic stress disorders in deployed veterans
11. New studies on cancer and schizophrenia, depression and heart disease, trauma and autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2008)...tic children whose parents have high expectations ...kely to have symptoms than other children dealing ...dren also are more likely to use asthma controller...for taking medicine and if their parents clearly u... The study, which appears in the Oct. 2008 issue o...
(Date:10/3/2008)...ding is beneficial. But can it help kids lose weig...terature on obese adolescents, researchers at Duke...ight type of novel may make a difference. , The ...who were already in a comprehensive weight loss pr... Rescue (Beacon Street Press). It was carefully cr...
(Date:10/3/2008)... Inc. Magazine recently included,Connolly Consulti...ng,private companies in the country. The list is t...egment of the economy -- America,s,independent-min...es,represent the backbone of the U.S. economy., (...3/NY36880LOGO ), Connolly Consulting,s consisten...
(Date:10/3/2008)...idents to Eat Right, Move More and ...t. 3 /PRNewswire/ -- The last decade can be define...hich seem to go in and out,of fashion like shoulde...en,slim. Two out of three Americans -- including 2...weight or obese., A new campaign crossing the cou...
Breaking Medicine News(10 mins):Health News:Children's asthma affected by parental expectations 2Health News:Duke researchers show reading can help obese kids lose weight 2Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3
...ry common disease of the present times; it is ofte... by way of incorporating specific foods has been f... could hold clues for future diabetes treatment, f...eep diabetes in check is always the best course of...
...eing pinned at a bird flu vaccine being manufactur...ny- Omninvest. Human trials in Hungary have shown ... influenza,// which has killed more than 60 people...produced an immune reaction to the H5N1 strain of ...
...atements by a 25 year old British man, Andrew Stim...itain's leading HIV/AIDS agency, the National AIDS...ing to // conclusions' about Stimpson's story, and...n, told two newspapers he had tested positive for ...
...rmarked $74 million to combat the bird flu threat ...rd was to announce the funding in Busan, Korea, wh...o-operation (APEC) forum. International agencies, ...ization (WHO), would get around 20 percent of the ...
Other Medicine News:Health News:Diet Effective In Curing Diabetes 2Health News:‘Miracle’ HIV Cure Claim Under Scrutin 2
(Date:10/6/2008)...se 3b Studies with Durezol Dosed Prior to Surgery,...peutics, Inc., a,privately held ophthalmic-focused...urezol(TM) (difluprednate ophthalmic emulsion) 0.0...as approved by the U.S. Food and,Drug Administrati...eroid,indicated for the treatment of inflammation ...
(Date:10/6/2008)...lif. and SEATTLE, Oct. 6 /- Complete,...human genome sequencing,company, and the Institute...artnership to conduct populationwide human genome ...enomics will use its proprietary,DNA sequencing te...vided by,ISB. Then, once proof-of-concept has been...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/6/2008)...Other Product - Company,s Bioabsorbable Stent - Al...G, Oct. 6 /- Data from multiple clini... OrbusNeich,s Genous Bio-engineered R,stent, will ...vascular,Therapeutics symposium, TCT 2008, in Wash...the Academic Medical Center in,Amsterdam will prov...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 1Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 8Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 1Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 2Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 3Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 1Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 2Food for thought 2735 2/ 1
... Jun 09, 2007 (MARKET WIRE via COMTEX News Network...sidiary of Endo,Pharmaceuticals Holdings Inc. (NAS... randomized, double-blind, placebo-controlled,clin...e) 2.5 mg,tablets as a six-day preventative treatm...raine (MM). The data demonstrated,that FROVA signi...
...., June 11, 2007--New research supported by the,...of Arthritis and,Musculoskeletal and Skin Diseas...ion gabapentin , which is used for certain,type...he pain and,other symptoms associated with the c..., fibromyalgia. , In the NIAMS-sponsored, random...
Other Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Gabapentin Shown Effective for Fibromyalgia Pain 2Gabapentin Shown Effective for Fibromyalgia Pain 3
BiodivYsio stent with biocompatible coating (phosphorylcholine)
The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, s
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support.
Medicine Products: